Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Rogers. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Rogers at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
Sponsor: Vanda Pharmaceuticals
Check if you qualify for this schizophrenia clinical trial in Rogers, AR
If you're searching for schizophrenia treatment options in Rogers, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rogers research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.